Real-time stock price, financial statements, consensus target price, insider trading, and technical analysis for Cellebrite DI Ltd. (CLBT:NASDAQ), powered by AI.
Cellebrite DI Ltd. is currently trading at $12.84. View real-time AI analysis on Alpha Lenz.
View the latest insider trading data for Cellebrite DI Ltd. on Alpha Lenz.
Cellebrite DI Ltd.'s P/E ratio is 39.6.
“Cellebrite DI Ltd. trades at a P/E of 39.6 (premium valuation) with strong ROE of 19.1%. 3Y revenue CAGR of 20.7% highlights clear growth momentum.”
Ask for details →Cellebrite DI Ltd. is a renowned company specializing in digital intelligence solutions for law enforcement, government, and enterprise sectors. The primary function of Cellebrite DI Ltd. is to enable its clients to securely and effectively analyze digital data, facilitating investigations and enhancing operational efficiency. It offers advanced software solutions and services that help in the extraction, deciphering, and analysis of complex digital information extracted from mobile phones and other digital devices. In doing so, Cellebrite DI Ltd. plays a crucial role in sectors such as cybersecurity, legal investigations, and data recovery, helping solve crimes and improving public safety. Headquartered in Israel, Cellebrite DI Ltd. is recognized globally for its technological innovation and expertise in digital forensics, contributing significantly to maintaining data integrity and security standards within the evolving digital landscape. By offering comprehensive digital intelligence platforms, Cellebrite consistently impacts how digital evidence is gathered and utilized across various industries, underlining its importance in modern data-centric environments.
“Cellebrite DI Ltd. trades at a P/E of 39.6 (premium valuation) with strong ROE of 19.1%. 3Y revenue CAGR of 20.7% highlights clear growth momentum.”
Ask for details →Cellebrite DI Ltd. (ticker: CLBT) is a company listed on NASDAQ in the Technology sector (Software - Infrastructure). It has approximately 1,167 employees. Market cap is $3.1B.
The current price is $12.84 with a P/E ratio of 39.61x and P/B of 6.41x.
ROE is 19.10% and operating margin is 13.98%. Annual revenue is $476M.